Cargando…

IL-6 as a therapeutic target in systemic-onset juvenile idiopathic arthritis

Detalles Bibliográficos
Autores principales:	Yokota, S, Miyamae, T, Imagawa, T, Mori, M
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833861/ http://dx.doi.org/10.1186/ar871

Ejemplares similares

Tocilizumab-effects on growth impairment in systemic juvenile idiopathic arthritis
por: Miyamae, Takako, et al.
Publicado: (2011)

Correlation between clinical indices and findings of joint ultrasonography in juvenile idiopathic arthritis with adalimumab therapy
por: Hara, Ryoki, et al.
Publicado: (2011)

2.1 Long-term safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis (JIA)
por: Yokota, S, et al.
Publicado: (2008)

Efficacy of thalidomide for a girl with inflammatory calicinosis, a severe complication of juvenile dermatomyosistis
por: Miyamae, T, et al.
Publicado: (2008)

MEFV mutations in Iranian children with systemic onset juvenile idiopathic arthritis
por: Farivar, Shirin, et al.
Publicado: (2014)

Serum protein profile in systemic-onset juvenile idiopathic arthritis differentiates response versus nonresponse to therapy
por: Miyamae, Takako, et al.
Publicado: (2005)

Anakinra treatment in patients with systemic-onset juvenil idiopathic arthritis: “The Valencia Experience”
por: Marvillet, I, et al.
Publicado: (2011)

Safety and efficacy of tocilizumab treatment in children with systemic onset of juvenile idiopathic arthritis
por: Alexeeva, E, et al.
Publicado: (2011)

The use of tocilizumab in a child with systemic onset juvenile idiopathic arthritis and ganglioneuroblastoma
por: Goran, Ristic, et al.
Publicado: (2011)

Efficacy and safety of tocilizumab in european children with systemic onset juvenile idiopathic arthritis
por: Nemiche, O, et al.
Publicado: (2011)

Macrophage activation sydrome with systemic onset juvenile idiopathic arthritis (SOJIA) in Chinese childern
por: Li, C, et al.
Publicado: (2008)

Development of consensus best treatment plans for new-onset systemic juvenile idiopathic arthritis
por: Morgan DeWitt, Esi M, et al.
Publicado: (2012)

22. Systemic onset juvenile idiopathic arthritis with multi-organ failure in a teenager
por: Law, Hannah, et al.
Publicado: (2019)

Chronic granulomatous disease associated with systemic lupus erythematosus and systemic onset juvenile idiopathic arthritis
por: Parvaneh, Vadood Javadi, et al.
Publicado: (2014)

Time of onset of iridocyclitis (IC) in children with juvenile idiopathic arthritis (JIA)
por: Verazza, S, et al.
Publicado: (2008)

Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis treated with tocilizumab
por: De Benedetti, Fabrizio, et al.
Publicado: (2014)

Systemic juvenile idiopathic arthritis in the republic of Bashkortostan
por: Malievskiy, VA
Publicado: (2011)

PADI4 and the HLA-DRB1 shared epitope in juvenile idiopathic arthritis
por: Hisa, Kaori, et al.
Publicado: (2017)

Fever without apparent sources in children: a nation-wide study in Japan
por: Kasai, K, et al.
Publicado: (2008)

Long-term follow-up of systemic onset juvenile idiopathic arthritis patients treated with Anakinra
por: Gattorno, Marco, et al.
Publicado: (2011)

Systemic onset Juvenile Idiopathic Arthritis (SoJIA): a monocentric study of 114 patients
por: Melki, I, et al.
Publicado: (2011)

PReS-FINAL-2104: Disease course and predictors of outcome in systemic onset juvenile idiopathic arthritis
por: Soponkanaporn, S, et al.
Publicado: (2013)

Turkish Pediatric Rheumatology Society consensus statements on systemic onset juvenile idiopathic arthritis in Turkey
por: Sozeri, B, et al.
Publicado: (2015)

Phenotypes of juvenile idiopathic arthritis
por: Rokhlina, Faina, et al.
Publicado: (2014)

PReS-FINAL-2060: The role of stress factors in the onset of juvenile idiopathic arthritis
por: Stepanenko, N, et al.
Publicado: (2013)

The correlations of serum interleukin-6 (il-6) levels and serum soluble il-6 receptor levels with disease activity in systemic juvenile idiopathic arthritis patients with and without tocilizumab treatment
por: Lerkvaleekul, Butsabong, et al.
Publicado: (2014)

Anakinra for systemic onset juvenile idiopathic arthritis: experience as a second versus first line treatment
por: Ricart, S, et al.
Publicado: (2011)

Macrophage activation syndrome due to systemic onset juvenile idiopathic arthritis in a case with liver transplantation
por: Ozturk, Kubra, et al.
Publicado: (2014)

Refractory systemic juvenile idiopathic arthritis complicated by coxarthrosis
por: Mellos, Antonio, et al.
Publicado: (2014)

Replication of the association of the COG6 gene with juvenile idiopathic arthritis (JIA)
por: Hinks, A, et al.
Publicado: (2011)

Juvenile idiopathic arthritis: the transition to adulthood
por: Fernandes, Susana, et al.
Publicado: (2014)

The TLR4 ligands MRP8 and MRP14 in the diagnosis and pathogenesis of systemic onset juvenile idiopathic arthritis
por: Frosch, M, et al.
Publicado: (2008)

Biologicals acting against interleukin 1 may reduce corticosteroid dependence in systemic onset juvenile idiopathic arthritis
por: Emminger, W, et al.
Publicado: (2011)

Osteonecrosis of the femoral heads in patients with systemic onset juvenile idiopathic arthritis: comparison of the results of radiological and morphological methods
por: Alexeev, D, et al.
Publicado: (2011)

PReS-FINAL-2113: The association of the NFKB1 gene polymorphism with systemic onset juvenile idiopathic arthritis in Russia
por: Malievsky, VA, et al.
Publicado: (2013)

Safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis
por: Horneff, G, et al.
Publicado: (2015)

PReS-FINAL-2166: Long-term safety and effectiveness of anti-interleukin-6 receptor monoclonal antibody, tocilizumab, in patients with systemic juvenile idiopathic arthritis in Japan
por: Yokota, S, et al.
Publicado: (2013)

A family case of early onset juvenile idiopathic arthritis with uveitis: lessons of the past and the present
por: Nikishina, Irina, et al.
Publicado: (2014)

Infectious adverse effects during treatment with IL-1 inhibitors in patients with systemic juvenile idiopathic arthritis and autoinflammatory diseases
por: Fernandez-Silveira, Laura, et al.
Publicado: (2014)

Interleukin-6 overproduction correlates with disease activity and severity in juvenile idiopathic arthritis
por: Spirchez, Mihaela, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_7026j0gg33e755th2epea5k24u